(Q34154885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Antidepressant treatment for acute bipolar depression: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Ben H Amit

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

27 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

Depression Research and Treatment

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

684725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

22 January 2020

copyright license

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

REVIEW: Patient, treatment, and systems-level factors in bipolar disorder nonadherence: A summary of the literature.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Evidence and implications for early intervention in bipolar disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Effectiveness of adjunctive antidepressant treatment for bipolar depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

An open trial of adjunctive escitalopram in bipolar depression.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Psychosocial Disability in the Course of Bipolar I and II Disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Review: in people with bipolar disorder, short term antidepressants improve clinical response, although tricyclics risk inducing mania

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Antidepressant-induced mania: an overview of current controversies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Suicidal behaviour in bipolar disorder: risk and prevention

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Prevalence and burden of bipolar disorders in European countries.

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Differences in incidence of suicide attempts during phases of bipolar I and II disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Extending indications for long-term pharmacotherapy: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

The duration of hypomania in bipolar-II disorder in private practice: methodology and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

One-year outcome with antidepressant--treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Risperidone and paroxetine given singly and in combination for bipolar depression.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Subsyndromal depression is associated with functional impairment in patients with bipolar disorder

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272786

Misdiagnosed Patients With Bipolar Disorder

28 October 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F684725

Practice guideline for the treatment of patients with bipolar disorder (revision)

21 January 2018

1 reference

12 December 2020

Antidepressants for bipolar depression

1 reference

12 December 2020

A double-blind study of tranylcypromine treatment of major anergic depression

1 reference

12 December 2020

Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression

1 reference

12 December 2020

International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression

1 reference

12 December 2020

Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders

1 reference

12 December 2020

Venlafaxine monotherapy in women with bipolar II and unipolar major depression

1 reference

12 December 2020

Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression

1 reference

12 December 2020

Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness

1 reference

12 December 2020

Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/684725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22319648%20AND%20SRC:MED&resulttype=core&format=json